Skip to Main Content
Table I.

Clinical characteristics of JIA patients included in the study


Patient

Sex

JIA form

Age

Disease duration

No. active jointsa

ESR

Treatment
   yr yr  mm/first hour  
polyarticular RF- 6.2 3.5 25 20 MTX, CyA 
extended oligoarticular 2.8 0.9 20 36 NSAID 
extended oligoarticular 9.5 7.1 96 MTX 
polyarticular RF- 5.4 0.8 27 53 NSAID 
extended oligoarticular 10.4 9.3 34 MTX 
systemic 4.3 1.7 97 MTX, CS 
extended oligoarticular 5.1 3.2 25 MTX 
extended oligoarticular 6.9 5.0 24 MTX 
polyarticular RF- 5.2 1.9 20 MTX, NSAID 
10 extended oligoarticular 6.3 5.2 60 MTX 
11 polyarticular RF- 9.9 8.5 34 CyA, NSAID 
12 systemic 10.3 0.8 16 96 MTX, NSAID 
13 persistent oligoarticular 8.5 7.1 12 
14 persistent oligoarticular 4.2 2.1 11 NSAID 
15 persistent oligoarticular 12.9 4.7 11 NSAID 
16 persistent oligoarticular 4.0 1.3 13 NSAID 
17 persistent oligoarticular 2.5 1.1 11 NSAID 
18 persistent oligoarticular 9.3 6.2 14 NSAID 
19 persistent oligoarticular 2.9 1.6 25 
20 persistent oligoarticular 11.9 3.1 26 NSAID 
21 persistent oligoarticular 6.0 1.6 36 
22 persistent oligoarticular 3.6 1.9 14 NSAID 
23 persistent oligoarticular 6.7 5.8 18 NSAID 
24 persistent oligoarticular 8.1 3.6 26 NSAID 
25
 
M
 
persistent oligoarticular
 
14.2
 
9.3
 
1
 
12
 
NSAID
 

Patient

Sex

JIA form

Age

Disease duration

No. active jointsa

ESR

Treatment
   yr yr  mm/first hour  
polyarticular RF- 6.2 3.5 25 20 MTX, CyA 
extended oligoarticular 2.8 0.9 20 36 NSAID 
extended oligoarticular 9.5 7.1 96 MTX 
polyarticular RF- 5.4 0.8 27 53 NSAID 
extended oligoarticular 10.4 9.3 34 MTX 
systemic 4.3 1.7 97 MTX, CS 
extended oligoarticular 5.1 3.2 25 MTX 
extended oligoarticular 6.9 5.0 24 MTX 
polyarticular RF- 5.2 1.9 20 MTX, NSAID 
10 extended oligoarticular 6.3 5.2 60 MTX 
11 polyarticular RF- 9.9 8.5 34 CyA, NSAID 
12 systemic 10.3 0.8 16 96 MTX, NSAID 
13 persistent oligoarticular 8.5 7.1 12 
14 persistent oligoarticular 4.2 2.1 11 NSAID 
15 persistent oligoarticular 12.9 4.7 11 NSAID 
16 persistent oligoarticular 4.0 1.3 13 NSAID 
17 persistent oligoarticular 2.5 1.1 11 NSAID 
18 persistent oligoarticular 9.3 6.2 14 NSAID 
19 persistent oligoarticular 2.9 1.6 25 
20 persistent oligoarticular 11.9 3.1 26 NSAID 
21 persistent oligoarticular 6.0 1.6 36 
22 persistent oligoarticular 3.6 1.9 14 NSAID 
23 persistent oligoarticular 6.7 5.8 18 NSAID 
24 persistent oligoarticular 8.1 3.6 26 NSAID 
25
 
M
 
persistent oligoarticular
 
14.2
 
9.3
 
1
 
12
 
NSAID
 
a

Defined as presence of swelling and/or limitation of motion with tenderness.

CS, corticosteroids, CyA, cyclosporin A; ESR, erythrocyte sedimentation rate; MTX, methotrexate; NSAID, nonsteroidal antiinflammatory drugs; RF, rheumatoid factor.

Close Modal

or Create an Account

Close Modal
Close Modal